Coronavirus and diabetes: the different risks for people with type 1 and type 2
Coronavirus: what a second wave might look like
Nicotine therapy for coronavirus: the evidence is weak and contradictory
Coronavirus weekly: recovery efforts happening in fits and starts
Four No's
Western Union Seeks To Buy MoneyGram; MGI Spikes 32%
June Monthly
Survey says UK public fears cyber-attacks with COVID-19 tracing app
US Dollar Losses are Extended, but Momentum Stalls in the European Morning
Macro Briefing | 1 June 2020
Microsoft Informs Journalists Their Services Are No Longer Needed Due to AI
Google Mulling Purchase of Stake in Indian Vodafone Idea
Adaptimmune Spikes 127% Post-ASCO; Analyst Triples Price Target
Coronavirus dashboard for May 31: comparing US States and regions with European countries
June Starts with a Bang
5-Star Analyst Pounds the Table on Roku Stock
Portfolio positioning for a recovery scenario
Bonhoeffer Fund 1Q20 Commentary: Combined Motor Holdings Case Study
Coronavirus news roundup – 29/05/2020
Month-End Profit-Taking Weighs on Equities as the Euro Pops Above $1.11
Oxford Biomedica signs COVID-19 vaccine supply deal with AZ
Top 10 fastest growing and declining retail brands in the world
Will Japan's $2.1 trillion stimulus send the Nikkei 20% higher?
GSK to produce a billion doses of COVID-19 vaccine booster by 2021
Escalating Tensions, Calm Markets
ABPI’s Sheuli Porkess on how COVID-19 could improve clinical trial conduct
Artificial intelligence spots COVID-19 in chest X-rays
A bit of active and a bit of passive investing makes sense
UK okays early access to Gilead’s remdesivir in seriously ill COVID-19 patients
China and Hong Kong Pressures are Having Limited Knock-on Effects